Cocrystal Pharma (COCP) Total Debt (2010 - 2013)
Cocrystal Pharma (COCP) posted Total Debt of $2.9 million for Q3 2013, down 5.72% sequentially from $3.1 million in Q2 2013, and down 5.73% YoY from $3.1 million in Q3 2012.
Cocrystal Pharma (COCP) Total Debt (2010 - 2013) Analysis & Trends
Cocrystal Pharma has reported Total Debt for 4 years, with the latest figure at $2.9 million in Q3 2013.
- Quarterly Total Debt fell 5.73% year-over-year to $2.9 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $2.9 million (down 5.73% YoY) and the FY2012 annual result came in at $3.3 million, down 8.46% from the prior year.
- Total Debt declined to $2.9 million in Q3 2013 per COCP's latest filing, from $3.1 million in the prior quarter.
- Over five years, Total Debt peaked at $3.6 million in Q4 2011 and troughed at $2.9 million in Q3 2013.
- A 4-year average of $3.3 million and a median of $3.3 million in 2010 frame the typical range for Total Debt.
- The sharpest annual moves came in 2011 and 2012: Total Debt increased 7.16% in 2011, then declined 8.46% in 2012.
- Over 4 years, Total Debt stood at $3.3 million in 2010, then advanced by 7.16% to $3.6 million in 2011, then slipped by 8.46% to $3.3 million in 2012, then slipped by 10.08% to $2.9 million in 2013.
- According to Business Quant data, Total Debt over the past three periods registered $2.9 million, $3.1 million, and $3.4 million for Q3 2013, Q2 2013, and Q1 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Cocrystal Pharma | 15.86 Mn | 13.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 2.93 Mn |
| Jun 30, 2013 | 3.11 Mn |
| Mar 31, 2013 | 3.37 Mn |
| Dec 31, 2012 | 3.26 Mn |
| Sep 30, 2012 | 3.11 Mn |
| Jun 30, 2012 | 3.39 Mn |
| Mar 31, 2012 | 3.24 Mn |
| Dec 31, 2011 | 3.56 Mn |
| Sep 30, 2011 | 3.37 Mn |
| Jun 30, 2011 | 3.45 Mn |
| Dec 31, 2010 | 3.32 Mn |